Added to YB: 2026-10-14
Pitch date: 2026-10-12
ETON [bullish]
Eton Pharmaceuticals, Inc.
-4.65%
current return
Author Info
Multibagger Ideas researches and shares thesis-driven ideas on potential multibaggers. Sign up for the newsletter.
Company Info
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases.
Market Cap
$1.6B
Pitch Price
$55.46
Price Target
N/A
Dividend
N/A
EV/EBITDA
62.44
P/E
128.99
EV/Sales
14.97
Sector
Pharmaceuticals
Category
growth
My Top 5 Multibagger Ideas For October - Eton Pharmaceuticals (NASDAQ: ETON)
ETON (earnings): Eton’s Q2 validated its self-funding model of adding acquired rare-disease drugs to fixed sales infrastructure: product sales rose 99% to $37.6M, adjusted EBITDA reached $16.2M at a 43% margin, and net income was $11.6M. Full-year guidance increased to >$145M revenue and ≥35% adjusted EBITDA margin. Meeting revenue guidance requires a >$41.5M quarterly second-half average; guidance already includes a $3M ASN-001 licensing expense in Q3.
Read full article (2 min)